Immune thrombocytopenia (ITP)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: Outpatients or inpatients who have been clinically diagnosed with chronic immune thrombocytopenia and have had a poor response to previous treatments such as glucocorticoids and immunoglobulins, and are under 18 years old. 2. Due to the need for treatment and the absence of alternative therapeutic drugs, TPO-RA is required. 3. The patient and the patient's guardian are willing for the patient to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: Exclusion criteria: Patients who have previously received TPO-RA treatment. 2. Patients whose conditions were determined by doctors to be urgent and critical, and who were not suitable to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The sustained response rate of patients; | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence of total bleeding events;The incidence rate of major clinical bleeding events;The proportion of patients requiring remedial treatment;Quality of life for women;Incremental cost-effectiveness ratio; | — |
Countries
China
Contacts
Guizhou Provincial People's Hospital